Leishmania donovani Dipeptidylcarboxypeptidase Inhibitor as a Potential Oral Treatment for Visceral Leishmaniasis. Ramalingam K, Gangwar S, Balodi DC, Anand A, et al. Antimicrob Agents Chemother 2022 Jul 19:e0236121. doi: 10.1128/aac.02361.

Read + Share

Amedeo Smart

Independent Medical Education

Ramalingam K, Gangwar S, Balodi DC, Anand A, et al. Leishmania donovani Dipeptidylcarboxypeptidase Inhibitor as a Potential Oral Treatment for Visceral Leishmaniasis. Antimicrob Agents Chemother 2022 Jul 19:e0236121. doi: 10.1128/aac.02361.
PMID: 35852367